InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
3
T+90 hit rate
57%
T+90 mean return
+4.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Posard Matthew L., Director. Director active across 3 companies, notably Halozyme Therapeutics, INC.. Aggregated, 15 filings have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €1.7m. History available since 5 May 2021. The latest transaction was disclosed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations15 total
4,165 shares0Common StockSEC:0001415889-25-011777:0
10,000 shares@ US$55.72333.2% of flowCommon StockSEC:0001415889-24-021305:0
10,000 shares@ US$50.01130.4% of flowCommon StockSEC:0001415889-24-016672:0
6,501 shares0Common StockSEC:0001415889-24-011705:0
35,714 shares0Common StockSEC:0001209191-23-034582:0
8,065 shares0Common StockSEC:0001415889-23-007694:0
10,000 shares@ US$58.8036.4% of flowCommon StockSEC:0001415889-22-012142:0
26,480 shares0Common StockSEC:0001209191-22-032989:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002912:0
20,000 shares@ US$4.570.033% mcap50.0% of flowCommon StockSEC:0001808805-21-000026:0
Ideal exit: 27 Aug 2022 (T+270)
20,000 shares@ US$4.57100.0% of flowCommon StockSEC:0001808805-21-000026
Ideal exit: 27 Aug 2022 (T+270)
4,497 shares0Common StockSEC:0001209191-21-036712:0
4,497 shares0Common StockSEC:0001209191-21-036712
5,230 sharesRestricted Stock UnitsSEC:0001179110-21-004974
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004974:0
15 of 15 declarations
About Posard Matthew L.
Posard Matthew L. is a Director at HALOZYME THERAPEUTICS, INC., DermTech, Inc., and Nautilus Biotechnology, Inc. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His experience in the biopharmaceutical sector is a valuable asset.
